First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity (Q21245463)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity |
scientific article |
Statements
First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity (English)
Joseph Gligorov
Joseph
Gligorov
Chrystelle Brignone
Maya Gutierrez
Fawzia Mefti
Etienne Brain
Rosana Jarcau
Frédérique Cvitkovic
Nabil Bousetta
Jacques Medioni
Caroline Grygar
Manon Marcu
Frédéric Triebel
23 July 2010
1
0 references
1 reference
1 reference
1 reference
1 reference
Identifiers
2 references
1 reference
2 references
2 references